Accéder au contenu
Merck

Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).

Bioorganic & medicinal chemistry letters (2008-12-23)
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Kristen E Nailor, James M Salovich, Stephon C Smith, Mui Cheung, Roseanne M Gerding, Kirk L Stevens, David E Uehling, Robert A Mook, Ganesh S Moorthy, Scott H Dickerson, Anne M Hassell, M Anthony Leesnitzer, Lisa M Shewchuk, Arthur Groy, Jason L Rowand, Kelly Anderson, Charity L Atkins, Jingsong Yang, Peter Sabbatini, Rakesh Kumar
RÉSUMÉ

The optimization of imidazo[1,2-a]pyridine inhibitors as potent and selective inhibitors of IGF-1R is presented. Further optimization of oral exposure in mice is also discussed. Detailed selectivity, in vitro activity, and in vivo PK profiles of an optimized compound is also highlighted.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Imidazo[1,2-a]pyridine, 99%